This week’s UK tech funding deals include inflammatory disease treatment developer Maxion Therapeutics, surgical device firm Eventum Orthapaedics and more.
UKTN tracked £67m worth of UK tech investment this week (17 March to 21 March), a 9% week-on-week decrease across five funding rounds.
Here’s your weekly roundup of UK tech startup funding deals.
Maxion Therapeutics – £58m
Sector: Health tech
HQ: Cambridge
Round: Series A
Investors: General Catalyst, British Patient Capital, Solasta Ventures and Eli Lilly and Company
Founded in 2020, Maxion Therapeutics is developing treatments for inflammatory diseases
Read more
Eventum Orthapaedics – £3.8m
Sector: Health tech
HQ: Leeds
Round: Early VC
Investors: Mercia Asset Management
Founded in 2020, Eventum Orthapaedics has developed the QuadSense device to provide real time data for surgeons.
Read more
EDX Medical – £3m
Sector: Health tech
HQ: Cambridge
Round: –
Investors: Sir Chris Evans (EDX founder), Dr Mike Hudson (CEO) and Martin Walton (board director and Deputy Chair)
Founded in 2021, EDX Medical has developed a “super test” for prostate cancer.
Read more
Qlarifi – £1.4m
Sector: Fintech
HQ: London
Round: Pre-seed
Investors: HoneyComb Asset Management, Carthona Capital and angels
Founded in 2023, Qlarifi provides underwriting data for BNPL lenders via consumers’ transaction history.
Read more
Bioniq – £840,000
Sector: Health tech
HQ: London
Round: –
Investors: Diogo Dalot
Founded in 2019, Bioniq develops personalised nutritional supplements.
Read more
The post UK tech funding roundup: This week’s deals from Maxion to Bioniq appeared first on UKTN.
